Tejnaksh Healthcare Ltd.
Snapshot View

140.00 -5.65 ▼-3.9%

18 August 2022, 04:01:00 PM
Volume: 16,778

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.tejnaksh.com
Market Cap 145.60 Cr.
Enterprise Value(EV) 145.49 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.49 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 56.31 Trailing Twelve Months Ending 2022-06
Industry PE 47.77 Trailing Twelve Months Ending 2022-06
Book Value / Share 20.32 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.89 Calculated using Price: 140.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.02 Cr. 10,156,800 Shares
FaceValue 10
Company Profile
The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.88%
1 Week
-3.01%
1 Month
-4.50%
3 Month
-2.64%
6 Month
-7.25%
1 Year
+45.23%
2 Year
+281.99%
5 Year
+83.99%
10 Year
6 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 21.17 26.68 34.98 26.93 15.10 12.71
Return on Capital Employed (%) 34.00 29.35 32.66 27.59 17.78 14.20
Return on Assets (%) 19.32 16.96 17.97 14.93 9.10 8.36

Balance Sheet View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 6 8 10 13 15 17 20
Non Curr. Liab. 0 7 6 6 7 5 7
Curr. Liab. 0 1 3 2 2 2 2
Minority Int. 0 0 0 0 0 1
Equity & Liab. 7 16 20 22 25 25 30
Non Curr. Assets 6 14 17 18 18 21 25
Curr. Assets 1 2 3 5 7 3 5
Misc. Exp. not W/O
Total Assets 7 16 20 22 25 25 30

Profit Loss View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 5 7 14 20 17 12 12
Other Income 0 0 0 2 0 0 0
Total Income 5 7 15 21 17 12 13
Total Expenditure -2 -4 -9 -16 -13 -8 -8
PBIDT 2 3 6 6 4 4 5
Interest 0 -1 -1 -1 -1 -1
Depreciation 0 0 0 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1
Exceptional Items
PAT 1 2 3 3 2 2 3
Minority Interest 0 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 1 2 3 3 2 2 3
Adjusted EPS 1 2 3 3 2 2 2

Cash Flow View Details >>

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 4 2 4 3 1 1
Cash Fr. Inv. -3 -8 -3 -2 -1 2
Cash Fr. Finan. 0 6 -1 -2 0 -3
Net Change 0 1 1 -1 0 0
Cash & Cash Eqvt 0 1 2 1 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 73.84 73.84 73.84 73.84 73.84 73.84 73.83 73.83 73.83
Public 26.16 26.16 26.16 26.16 26.16 26.16 26.17 26.17 26.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance of provision of Regulation 47 read with Regulation 33 of the SEBI (LODR) Regulations 2015 the Company has published the Un-Audited Financial Results for the quarter ended on 30th June 2022 which has been approved by Board of Directors at the Board Meeting held on Thursday 11th August 2022.The financial results were published in Active Times (English Newspaper) and MumbaiLakshadweep (Marathi Newspaper) on 12"August 2022.
Thu, 11 Aug 2022
Board Meeting Outcome for The Outcome Of Board Meeting Held On 11.08.2022
In continuation of our Letter dated 02TH August 2022 We wish to inform you that a meeting of the Boardof Directors of the Company was held on Thursday 11TH August 2022 at A 601 Floor No.6 KailashBusiness Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 at 12.00 p.m.
Thu, 11 Aug 2022
Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30"June 2022.
Please find the enclosed herewith Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended on 30" June 2022 along with Limited Review Report thereon approved by the Board of Directors of the Company at its Meeting held on Thursday 11"August 2022 at A 601 Floor No.6
«ailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 at 12.00 p.m. in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Thu, 18 Aug 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Making Lower Lows for 3 days Making Lower Lows for 3 days
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years
Close Crossing 200 SMA From Above Close Crossing 200 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,779.08 916.00 -0.5%
Divi's Laboratories Ltd. 99,402.06 3,744.40 -0.1%
Cipla Ltd. 83,298.12 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. 70,326.13 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. 61,347.88 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. 52,831.33 1,564.95 +0.5%
Piramal Enterprises Ltd. 46,812.69 1,961.10 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.51 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 32.01 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 33.50 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.51 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.51 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.12 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.90 1,961.10 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 8.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 3.88 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.47 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.33 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.31 1,961.10 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,961.10 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,961.10 -0.7%

FAQ's On Tejnaksh Healthcare Ltd.

Can I Buy Tejnaksh Healthcare Shares now?

What is the Share Price of Tejnaksh Healthcare?

What is the Relative Strength Index (RSI) Value of Tejnaksh Healthcare?

What is the Market Capital (MCAP) of Tejnaksh Healthcare?

What are the key metrics to analyse Tejnaksh Healthcare?

What is the Price Performance of Tejnaksh Healthcare?